Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: John F. Dowd who wrote (8301)	11/21/1999 2:25:00 AM
From: synchro	Respond to of 9523

Very little chance that PFE will become a target. Even at current prices PFE is worth $130 billion with the highest PE amongst its peers. Any stock deal will be hugely dilutive to the acquirer.

To: John F. Dowd who wrote (8301)	11/21/1999 11:44:00 AM
From: Stephen M. DeMoss	Read Replies (1) \| Respond to of 9523

I agree. PFE will go up either way. The stock price is very depressed here and has factored in all negatives that aquisitions sometimes bring. The company has already stated that earnings and growth look strong for the next 2 quarters. The uncertainty of this hostile bid is what has depressed the stock. This is the time to accumulate. The stock will be at 50 within twelve months (reasonable target). I will continue to buy and sell out of the money calls near term as the stock slowly climbs. Steve D.